Proteomic changes in cancer cell lines as a result of bacterial infection
| dc.contributor.author | Ren, Bo | |
| dc.contributor.author | Weke, Kenneth | |
| dc.contributor.author | Hardie, Darryl | |
| dc.contributor.author | Goncheva, Mariya I. | |
| dc.contributor.author | Hupp, Ted | |
| dc.contributor.author | Alfaro, Javier Antonio | |
| dc.contributor.author | Pětrošová, Helena | |
| dc.contributor.author | Goodlett, David R. | |
| dc.date.accessioned | 2026-05-07T17:31:18Z | |
| dc.date.available | 2026-05-07T17:31:18Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Bacterial infections have been implicated in shaping the tumor microenvironment (TME), but their effects on cancer cell proteomes remain unexplored. In this study, we analyzed proteomic changes in melanoma (A375) and ovarian cancer (OVCAR3) cell line models following infection with Staphylococcus aureus strain USA300 or Salmonella enterica strain SL1344 using mass spectrometry-based label-free quantitative proteomics. Bacterial infection leads to widespread changes in host protein expression in the cancer cells, with levels of proteins involved in mitochondrial metabolism, RNA processing, and cellular stress response all increasing in relative abundance. In contrast, proteins involved in DNA repair, cytoskeletal structure, vesicle trafficking, and cell cycle regulation were consistently downregulated. The magnitude of the observed changes varied by the cancer cell type. Understanding these interactions may provide new directions for the role of bacteria in tumor progression and therapeutic resistance. | |
| dc.description.reviewstatus | Reviewed | |
| dc.description.scholarlevel | Faculty | |
| dc.description.sponsorship | We would like to thank Dr. Lisa Reynolds (University of Victoria, BC, Canada) for providing the S. enterica SL1344 strain. D.R.G. and the work performed at the University of Victoria-Genome BC Proteomics Centre (UVic-PC) was supported by funding to the BC Proteomics Centre (BCPC) from Genome British Columbia, for operations and technology development (374PRO). M.I.G. was supported by an NSERC Discovery Grant RGPIN-2024-04587. J.A.A. was supported by funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 101017453. | |
| dc.identifier.citation | Ren, B., Weke, K., Hardie, D., Goncheva, M. I., Hupp, T., Alfaro, J. A., P?trošová, H., & Goodlett, D. R. (2025). Proteomic changes in cancer cell lines as a result of bacterial infection. Proteomics, e70062. https://doi.org/10.1002/pmic.70062 | |
| dc.identifier.uri | https://doi.org/10.1002/pmic.70062 | |
| dc.identifier.uri | https://hdl.handle.net/1828/23839 | |
| dc.language.iso | en | |
| dc.publisher | Proteomics | |
| dc.rights | CC BY-NC-ND | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | UVic Genome BC Proteomics Centre | |
| dc.subject | Sexual and Reproductive Health and Rights (SRHR) Aspiration Research Cluster | |
| dc.subject | bacterial infection | |
| dc.subject | cancer cells | |
| dc.subject | proteomics | |
| dc.subject | tumor microenvironment | |
| dc.subject.department | Department of Biochemistry and Microbiology | |
| dc.title | Proteomic changes in cancer cell lines as a result of bacterial infection | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1